Recent Advances in Synthetic Quinoline-Based Compounds in Anticancer Drug Design
Molecules · 06.11.2026 · 31 (21) · 4000
DOI: 10.3390/molecules31214000 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 06.11.2026. Verfasst von Łukasz Balewski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland. Hauptthemen laut MEDLINE: Antineoplastic Agents, Quinolines, Drug Design, Neoplasms. Die Arbeit nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Gdańsk, Medical University of Gdańsk, Poland.
Abstract (Originalsprache)
Compounds based on the quinoline (benzo[b]pyridine, 2,3-benzopyridine, or 1-azanaphthalene) core demonstrate extensive biological functionality. In recent years, scientific interest has converged on their antitumor properties, where they trigger antiproliferative responses through a variety of mechanisms, including the targeting of distinct signaling cascades. To overcome the limitations of high-specificity targeted therapies such as tumor resistance, recent research has shifted toward multi-target therapeutic strategies. The lack of strict drug specificity may be an advantage, offering improved pharmacodynamics. Compared to highly specific therapies, this multi-target strategy potentially may reduce the risks of cancer resistance. This review provides a comprehensive analysis of recent studies on the most critical targets for anticancer quinoline-based derivatives, detailing their mechanisms of inhibition or activation across various proteins, enzymes, and signaling pathways. These targets span receptor tyrosine kinases as well as cell-surface receptor complexes and integrin signaling modules. Inside the cell, quinolines modulate intracellular signaling and nuclear transcription factors alongside epigenetic factors. Furthermore, these compounds dictate cell cycle regulation and mitotic arrest. They also influence DNA integrity and post-translational modifications. Finally, quinolines address tumor microenvironment adaptation and efflux-mediated resistance. A wide array of anticancer activities indicates that quinolines may inhibit tubulin polymerization and induce apoptosis via caspase, or ROS-mediated pathways. Finally, due to the presence of aromatic nitrogen atoms, the quinoline derivatives constitute appropriate ligands that may be employed in the development of metal complexes. It has been demonstrated that such compounds, including 8-hydroxyquinoline-containg ligands, possess exceptional coordination abilities and transition metal recognizing properties. Various quinoline chelates containing calcium, nickel, zinc, ruthenium, hafnium, or silver possess improved anticancer properties which place them in a leading position for the development of effective chemotherapeutic agents. Given the vast amount of literature, this review summarizing the recent developments on synthetic quinoline-containing compounds and their metal complexes with proven anticancer properties is restricted to the short period with an emphasis on the 2025–2026 literature, while including essential background from earlier recent work (2022–2024).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland.
ORCID-Profile: Łukasz Balewski, Chintankumar Padariya, Anita Kornicka
Förderung
- Medical University of Gdańsk
- Medical University of Gdańsk, Poland
Zitieren
APA
Balewski, Ł., Padariya, C., & Kornicka, A. (2026). Recent Advances in Synthetic Quinoline-Based Compounds in Anticancer Drug Design. Molecules, 31(21), 4000. https://doi.org/10.3390/molecules31214000
Vancouver
Balewski Ł, Padariya C, Kornicka A. Recent Advances in Synthetic Quinoline-Based Compounds in Anticancer Drug Design. Molecules. 2026;31(21):4000. doi:10.3390/molecules31214000
BibTeX
@article{Balewski2026,
author = {Balewski, Łukasz and Padariya, Chintankumar and Kornicka, Anita},
title = {Recent Advances in Synthetic Quinoline-Based Compounds in Anticancer Drug Design},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {4000},
doi = {10.3390/molecules31214000}
}
EUVIMED